File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1101/sqb.2016.81.031161
- Scopus: eid_2-s2.0-85021010297
- PMID: 28057846
- WOS: WOS:000483100500012
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Beyond the oncogene revolution: Four new ways to combat cancer
Title | Beyond the oncogene revolution: Four new ways to combat cancer |
---|---|
Authors | |
Issue Date | 2016 |
Citation | Cold Spring Harbor Symposia on Quantitative Biology, 2016, v. 81, n. 1, p. 85-92 How to Cite? |
Abstract | It has become clear that tumorigenesis results from much more than just the activation of an oncogene and/or the inactivation of a tumor-suppressor gene, and that the cancer cell genome contains many more alterations than can be specifically targeted at once. This observation has led our group to a search for alternative ways to kill cancer cells (while sparing normal cells) by focusing on properties unique to the former.We have identified four approaches with the potential to generate new anticancer therapies: combatting the tactics by which cancers evade antitumor immune responses, targeting metabolic adaptations that tumor cells use to survive conditions that would kill normal cells, manipulating a cancer cell's response to excessive oxidative stress, and exploiting aneuploidy. This review describes our progress to date on these fronts. |
Persistent Identifier | http://hdl.handle.net/10722/293020 |
ISSN | 2020 SCImago Journal Rankings: 1.615 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Berger, Thorsten | - |
dc.contributor.author | Saunders, Mary E. | - |
dc.contributor.author | Mak, Tak W. | - |
dc.date.accessioned | 2020-11-17T14:57:42Z | - |
dc.date.available | 2020-11-17T14:57:42Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Cold Spring Harbor Symposia on Quantitative Biology, 2016, v. 81, n. 1, p. 85-92 | - |
dc.identifier.issn | 0091-7451 | - |
dc.identifier.uri | http://hdl.handle.net/10722/293020 | - |
dc.description.abstract | It has become clear that tumorigenesis results from much more than just the activation of an oncogene and/or the inactivation of a tumor-suppressor gene, and that the cancer cell genome contains many more alterations than can be specifically targeted at once. This observation has led our group to a search for alternative ways to kill cancer cells (while sparing normal cells) by focusing on properties unique to the former.We have identified four approaches with the potential to generate new anticancer therapies: combatting the tactics by which cancers evade antitumor immune responses, targeting metabolic adaptations that tumor cells use to survive conditions that would kill normal cells, manipulating a cancer cell's response to excessive oxidative stress, and exploiting aneuploidy. This review describes our progress to date on these fronts. | - |
dc.language | eng | - |
dc.relation.ispartof | Cold Spring Harbor Symposia on Quantitative Biology | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | Beyond the oncogene revolution: Four new ways to combat cancer | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1101/sqb.2016.81.031161 | - |
dc.identifier.pmid | 28057846 | - |
dc.identifier.scopus | eid_2-s2.0-85021010297 | - |
dc.identifier.volume | 81 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 85 | - |
dc.identifier.epage | 92 | - |
dc.identifier.eissn | 1943-4456 | - |
dc.identifier.isi | WOS:000483100500012 | - |
dc.identifier.issnl | 0091-7451 | - |